BioNTech SE (BNTX) moved lower in recent intraday trading after encountering resistance at its 50-day Simple Moving Average (SMA), which triggered renewed selling pressure and forced the stock into a pullback. The decline comes as momentum indicators have reached extremely overbought levels, to a degree that appears excessive relative to the stock's price action. Meanwhile, the primary short-term bearish trend remains firmly in control.

Accordingly, our outlook remains tilted to the downside for the stock's upcoming trading sessions as long as resistance at $97.45 remains intact. Under this scenario, the stock is expected to target the $85.00 support level.

Today's price forecast: Neutral.